T-cell redirecting bispecific antibodies for treatment of disease

T-cell redirecting bispecific antibodies for treatment of disease

  • CN 104,379,169 A
  • Filed: 08/14/2013
  • Published: 02/25/2015
  • Est. Priority Date: 08/14/2012
  • Status: Active Application
First Claim
Patent Images

1. a method for disease therapy, it comprises:

  • A) use T-cell to the experimenter suffering from described disease and be redirected complex with the immune response for the target cell joined with described disease association of inducing T-cell-mediated;

    AndB) interferon be selected from by the following group formed is used to described experimenter;

    interferon-'"'"' alpha '"'"', interferon-beta, interferon-λ

    1, interferon-λ

    2 and interferon-λ

    3.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×